Literature DB >> 8976652

Spontaneous growth in idiopathic short stature. European Study Group.

L T Rekers-Mombarg1, J M Wit, G G Massa, M B Ranke, J M Buckler, O Butenandt, J L Chaussain, H Frisch, E Leiberman.   

Abstract

Documenting the spontaneous growth pattern of children with idiopathic short stature (ISS) should be helpful in evaluating the effects of growth promoting treatments. Growth curves for children with ISS were constructed, based on 229 untreated children (145 boys and 84 girls) from nine European countries. The children were subdivided according to target range and onset of puberty, and the growth of these subgroups was evaluated from standard deviation scores (SDS). At birth, children with ISS were already shorter than normal (means; boys -0.8 SDS, girls -1.3 SDS). Height slowly decreased from -1.7 SDS at the age of 2 years to -2.7 SDS at the age of 16 years in boys and 13 years in girls. Final height was -1.5 SDS in boys and -1.6 SDS in girls (mean (SD): boys 164.8 (6.1) cm, girls 152.7 (5.3) cm)), which was 5-6 cm below their target height. The onset of puberty was delayed (boys 13.8 (1.3) years, girls 12.9 (1.1) years). Subclassification resulted in similar growth curves. These specific growth data may be more suitable for evaluating the effects of growth promoting treatments than population based references.

Entities:  

Mesh:

Year:  1996        PMID: 8976652      PMCID: PMC1511692          DOI: 10.1136/adc.75.3.175

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  22 in total

1.  Towards a consensus on the definition of idiopathic short stature.

Authors:  M B Ranke
Journal:  Horm Res       Date:  1996

2.  Intrauterine growth of live-born Caucasian infants at sea level: standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeks of gestation.

Authors:  R Usher; F McLean
Journal:  J Pediatr       Date:  1969-06       Impact factor: 4.406

3.  Characteristics of children with idiopathic short stature in the Kabi Pharmacia International Growth Study, and their response to growth hormone treatment. International Board of the Kabi Pharmacia International Growth Study.

Authors:  K Albertsson-Wikland
Journal:  Acta Paediatr Suppl       Date:  1993-09

4.  Final height in boys with untreated constitutional delay in growth and puberty.

Authors:  E C Crowne; S M Shalet; W H Wallace; D M Eminson; D A Price
Journal:  Arch Dis Child       Date:  1990-10       Impact factor: 3.791

5.  Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. II.

Authors:  J M Tanner; R H Whitehouse; M Takaishi
Journal:  Arch Dis Child       Date:  1966-12       Impact factor: 3.791

6.  Predictive factors in the determination of final height in boys with constitutional delay of growth and puberty.

Authors:  A Albanese; R Stanhope
Journal:  J Pediatr       Date:  1995-04       Impact factor: 4.406

7.  Spontaneous adult height in idiopathic short stature.

Authors:  M B Ranke; M L Grauer; K Kistner; W F Blum; H A Wollmann
Journal:  Horm Res       Date:  1995

8.  Growth response of children with non-growth-hormone deficiency and marked short stature during three years of growth hormone therapy.

Authors:  N J Hopwood; R L Hintz; J M Gertner; K M Attie; A J Johanson; J Baptista; J Kuntze; R M Blizzard; J F Cara; S D Chernausek
Journal:  J Pediatr       Date:  1993-08       Impact factor: 4.406

9.  Final height in girls with untreated constitutional delay in growth and puberty.

Authors:  E C Crowne; S M Shalet; W H Wallace; D M Eminson; D A Price
Journal:  Eur J Pediatr       Date:  1991-08       Impact factor: 3.183

10.  Final height and predicted height in boys with untreated constitutional growth delay.

Authors:  M Sperlich; O Butenandt; H P Schwarz
Journal:  Eur J Pediatr       Date:  1995-08       Impact factor: 3.183

View more
  8 in total

Review 1.  The use of somatropin (recombinant growth hormone) in children of short stature.

Authors:  Ameeta Mehta; Peter C Hindmarsh
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 2.  Aromatase inhibitors in pediatrics.

Authors:  Jan M Wit; Matti Hero; Susan B Nunez
Journal:  Nat Rev Endocrinol       Date:  2011-10-25       Impact factor: 43.330

3.  A Novel Method for Adult Height Prediction in Children With Idiopathic Short Stature Derived From a German-Dutch Cohort.

Authors:  Werner F Blum; Michael B Ranke; Eberhard Keller; Alexandra Keller; Sandra Barth; Christiaan de Bruin; Stefan A Wudy; Jan M Wit
Journal:  J Endocr Soc       Date:  2022-05-06

4.  Managing idiopathic short stature: role of somatropin (rDNA origin) for injection.

Authors:  J Paul Frindik; Stephen F Kemp
Journal:  Biologics       Date:  2010-06-24

Review 5.  Treatment of children and adolescents with idiopathic short stature.

Authors:  Michael B Ranke
Journal:  Nat Rev Endocrinol       Date:  2013-04-23       Impact factor: 43.330

6.  Growth hormone deficiency and antipituitary antibodies in a patient with common variable immunodeficiency.

Authors:  M Delvecchio; A De Bellis; D De Mattia; L Cavallo; B Martire
Journal:  J Endocrinol Invest       Date:  2009-05-26       Impact factor: 4.256

7.  A randomized pilot trial of growth hormone with anastrozole versus growth hormone alone, starting at the very end of puberty in adolescents with idiopathic short stature.

Authors:  Anya Rothenbuhler; Agnès Linglart; Pierre Bougnères
Journal:  Int J Pediatr Endocrinol       Date:  2015-02-16

8.  Growth hormone significantly increases the adult height of children with idiopathic short stature: comparison of subgroups and benefit.

Authors:  Juan F Sotos; Naomi J Tokar
Journal:  Int J Pediatr Endocrinol       Date:  2014-07-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.